201 related articles for article (PubMed ID: 9147642)
1. Association of the steroid synthesis gene CYP11a with polycystic ovary syndrome and hyperandrogenism.
Gharani N; Waterworth DM; Batty S; White D; Gilling-Smith C; Conway GS; McCarthy M; Franks S; Williamson R
Hum Mol Genet; 1997 Mar; 6(3):397-402. PubMed ID: 9147642
[TBL] [Abstract][Full Text] [Related]
2. Role of the pentanucleotide (tttta)(n) polymorphism in the promoter of the CYP11a gene in the pathogenesis of hirsutism.
San Millán JL; Sancho J; Calvo RM; Escobar-Morreale HF
Fertil Steril; 2001 Apr; 75(4):797-802. PubMed ID: 11287037
[TBL] [Abstract][Full Text] [Related]
3. [Polymorphism in CYP11alpha and CYP17 genes and the etiology of hyperandrogenism in patients with polycystic ovary syndrome].
Pérez MS; Cerrone GE; Benencia H; Márquez N; De Piano E; Frechtel GD
Medicina (B Aires); 2008; 68(2):129-34. PubMed ID: 18499961
[TBL] [Abstract][Full Text] [Related]
4. [Genetic aspects of polycystic ovary syndrome].
Jakubowski L
Endokrynol Pol; 2005; 56(3):285-93. PubMed ID: 16350721
[TBL] [Abstract][Full Text] [Related]
5. Large-scale analysis of the relationship between CYP11A promoter variation, polycystic ovarian syndrome, and serum testosterone.
Gaasenbeek M; Powell BL; Sovio U; Haddad L; Gharani N; Bennett A; Groves CJ; Rush K; Goh MJ; Conway GS; Ruokonen A; Martikainen H; Pouta A; Taponen S; Hartikainen AL; Halford S; Järvelin MR; Franks S; McCarthy MI
J Clin Endocrinol Metab; 2004 May; 89(5):2408-13. PubMed ID: 15126571
[TBL] [Abstract][Full Text] [Related]
6. Impact of rs2414096 polymorphism of CYP19 gene on susceptibility of polycystic ovary syndrome and hyperandrogenism in Kashmiri women.
Ashraf S; Rasool SUA; Nabi M; Ganie MA; Masoodi SR; Amin S
Sci Rep; 2021 Jun; 11(1):12942. PubMed ID: 34155264
[TBL] [Abstract][Full Text] [Related]
7. Genetics of polycystic ovary syndrome.
Franks S; Gharani N; Waterworth D; Batty S; White D; Williamson R; McCarthy M
Mol Cell Endocrinol; 1998 Oct; 145(1-2):123-8. PubMed ID: 9922108
[TBL] [Abstract][Full Text] [Related]
8. Role of the pentanucleotide (tttta)n polymorphisms of Cyp11alpha gene in the pathogenesis of hyperandrogenism in Chinese women with polycystic ovary syndrome.
Tan L; Zhu G
J Huazhong Univ Sci Technolog Med Sci; 2005; 25(2):212-4. PubMed ID: 16116976
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of theca-cell messenger RNA in polycystic ovary syndrome does not correlate with polymorphisms in the cholesterol side-chain cleavage and 17alpha-hydroxylase/C(17-20) lyase promoters.
Daneshmand S; Weitsman SR; Navab A; Jakimiuk AJ; Magoffin DA
Fertil Steril; 2002 Feb; 77(2):274-80. PubMed ID: 11821083
[TBL] [Abstract][Full Text] [Related]
10. SNP rs2470152 in CYP19 is correlated to aromatase activity in Chinese polycystic ovary syndrome patients.
Zhang XL; Zhang CW; Xu P; Liang FJ; Che YN; Xia YJ; Cao YX; Wu XK; Wang WJ; Yi L; Gao Q; Wang Y
Mol Med Rep; 2012 Jan; 5(1):245-9. PubMed ID: 21972004
[TBL] [Abstract][Full Text] [Related]
11. Aromatase gene polymorphism does not influence clinical phenotype and response to oral contraceptive pills in polycystic ovary syndrome women.
Maier PS; Spritzer PM
Gynecol Obstet Invest; 2012; 74(2):136-42. PubMed ID: 22889864
[TBL] [Abstract][Full Text] [Related]
12. Polycystic ovary syndrome: evidence for a primary disorder of ovarian steroidogenesis.
Franks S; Gharani N; Gilling-Smith C
J Steroid Biochem Mol Biol; 1999; 69(1-6):269-72. PubMed ID: 10419001
[TBL] [Abstract][Full Text] [Related]
13. The synergistic effect of sex hormone-binding globulin and aromatase genes on polycystic ovary syndrome phenotype.
Xita N; Georgiou I; Lazaros L; Psofaki V; Kolios G; Tsatsoulis A
Eur J Endocrinol; 2008 Jun; 158(6):861-5. PubMed ID: 18505907
[TBL] [Abstract][Full Text] [Related]
14. Microsatellite polymorphism (tttta)(n) at -528 base pairs of gene CYP11alpha influences hyperandrogenemia in patients with polycystic ovary syndrome.
Diamanti-Kandarakis E; Bartzis MI; Bergiele AT; Tsianateli TC; Kouli CR
Fertil Steril; 2000 Apr; 73(4):735-41. PubMed ID: 10731534
[TBL] [Abstract][Full Text] [Related]
15. CAG repeat polymorphism in androgen receptor gene is not directly associated with polycystic ovary syndrome but influences serum testosterone levels.
Skrgatic L; Baldani DP; Cerne JZ; Ferk P; Gersak K
J Steroid Biochem Mol Biol; 2012 Feb; 128(3-5):107-12. PubMed ID: 22107839
[TBL] [Abstract][Full Text] [Related]
16. The genetic basis of polycystic ovary syndrome.
Franks S; Gharani N; Waterworth D; Batty S; White D; Williamson R; McCarthy M
Hum Reprod; 1997 Dec; 12(12):2641-8. PubMed ID: 9455828
[TBL] [Abstract][Full Text] [Related]
17. [Microsatellite polymorphism of (tttta) n in the promoter of CYP11a gene in Chinese women with polycystic ovary syndrome].
Wang Y; Wu XK; Cao YX; Yi L; Zou Y; Qu JW; Hou LH
Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(48):3396-400. PubMed ID: 16409859
[TBL] [Abstract][Full Text] [Related]
18. A genetic risk score is associated with polycystic ovary syndrome-related traits.
Lee H; Oh JY; Sung YA; Chung HW
Hum Reprod; 2016 Jan; 31(1):209-15. PubMed ID: 26573528
[TBL] [Abstract][Full Text] [Related]
19. Some new thoughts on the pathophysiology and genetics of polycystic ovary syndrome.
Strauss JF
Ann N Y Acad Sci; 2003 Nov; 997():42-8. PubMed ID: 14644808
[TBL] [Abstract][Full Text] [Related]
20. CYP17 gene polymorphic sequence variation is associated with hyperandrogenism in Kashmiri women with polycystic ovarian syndrome.
Ashraf S; Rasool SUA; Nabi M; Ganie MA; Jabeen F; Rashid F; Amin S
Gynecol Endocrinol; 2021 Mar; 37(3):230-234. PubMed ID: 32456493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
